Amphastar Pharmaceuticals (AMPH) Minority Interest (2018 - 2021)

Amphastar Pharmaceuticals' Minority Interest history runs 4 years deep, the most recent figure standing at $45.2 million for Q2 2021.

• In Q2 2021, Minority Interest changed N/A year-over-year to $45.2 million; the TTM figure through Jun 2021 stood at $45.2 million (changed N/A YoY), while the FY2020 annual figure was $46.4 million, up 0.55% from the prior year.
• Minority Interest was $45.2 million for Q2 2021 at Amphastar Pharmaceuticals, roughly flat from $45.4 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $46.4 million in Q4 2020 to a low of $21.9 million in Q3 2018.
• Historically, Minority Interest has averaged $42.0 million across 4 years, with a median of $45.3 million in 2019.
• The sharpest annual moves came in 2019 and 2021: Minority Interest surged 102.47% in 2019, then slipped 1.0% in 2021.
• A 4-year view of Minority Interest shows it stood at $31.9 million in 2018, then soared by 44.6% to $46.2 million in 2019, then rose by 0.55% to $46.4 million in 2020, then dropped by 2.56% to $45.2 million in 2021.
• The last three Minority Interest figures came in at $45.2 million (Q2 2021), $45.4 million (Q1 2021), and $46.4 million (Q4 2020), per Business Quant data.